Best in Biotech 24 Oct 2024
Six biotech companies advancing multiple sclerosis therapies
Take a look at six multiple sclerosis companies trying to make a difference to patients by advancing new treatments for the CNS disease.
Autoimmune disease
- Latest Posts
ADCs that deliver: The secret lies in rigorous characterization
Explore the challenges of ADC characterization, key techniques, and the benefits of partnering with a CDMO for effective development.
The crucial role of GS-CHO innovation in biopharmaceutical progress
Learn how GS-CHO systems are advancing to improve yields and quality in biomanufacturing, meeting the rising need for effective therapeutic proteins.
News and Trends 14 Aug 2024
CAR-T drugs and parkinsonism: a cause for concern?
CAR-T therapies come with boxed warnings of serious neurotoxic side effects. Now, growing concerns over parkinsonism have led to a clinical trial halt.
In Depth 30 Jul 2024
Why is the immunology and inflammation market suddenly attracting a wave of investment?
Discover why the immunology and inflammation market has recently been attracting a major wave of investment.
Podcast 24 May 2024
How biotech is tackling myasthenia gravis
To talk about the disease, how it is being treated, and what is in the pipeline for future treatments, we had a conversation with Dana Vigier, head of Central Eastern and Northern Europe at Alexion.
ADVERTISEMENT
ADVERTISEMENT
In Depth 9 May 2024
BTK inhibitors: can these drugs tackle cancer and autoimmunity?
BTK inhibitors were first approved over a decade ago to treat a rare blood cancer. Now, they are in the running to treat a host of autoimmune diseases.
Best in Biotech 23 Apr 2024
Eight biotechnology companies leading the charge in Poland
Discover eight biotech companies at the forefront of Poland’s emerging biotech sector, which is becoming a hotspot for startups.
In Depth 27 Mar 2024
Are new treatments for multiple sclerosis on the horizon?
As the wait for new multiple sclerosis treatments continue, here are some ongoing clinical trials that hold promise.
In Depth 7 Mar 2024
Can AbbVie’s legacy live beyond its once best-selling drug Humira?
The sales of AbbVie’s Humira, once a best-seller, have dropped. Now, with a new CEO announced, things are about to change for the company.
Protein inhibitors: cracking the code of disease mechanisms
Explore how protein inhibitors revolutionize disease understanding, by unlocking the secrets of disease pathways.
Podcast 2 Feb 2024
BioSenic showcasing knee osteoarthritis treatment
Explore a groundbreaking approach to knee osteoarthritis treatment with BioSenic’s JTA-004. Listen to our podcast to learn more!
ADVERTISEMENT
